As a dangerous prescription drug attorney,I have paid close attention to the diabetes drug Avandia (rosiglitazone) ever since a 2007 study showed it increased risk of heart attacks substantially. That…
Read More
The psychiatric drug Zyprexa (olanzapine) has been at the center of several controversies interesting to defective drug attorneys like me, due to its illegal off-label marketing and its connection with…
Read More
According to a new study that is to be published in the March issue of the Journal of Studies on Alcohol and Drugs, depression caused by drinking heavily may be…
Read More
As a defective prescription drug attorney, I am familiar with at least one older study linking a class of anemia drugs to potentially life-threatening blood clots. On Nov. 10, a…
Read More
A Massachusetts woman named Lisa A. Moon has filed a new Yaz lawsuit on January 23, 2013, in the U.S. District Court for the Southern District of Illinois against Bayer.…
Read More
As a dangerous drug injury attorney, I was disappointed to see two new studies on the use of risky atypical antipsychotic drugs. According to a Jan. 11 article from HealthDay,…
Read More
As a pharmaceutical liability attorney, I was disturbed to read about a new warning of serious side effects for the antidepressant Norpramin (desipramine hydrochloride). According to a Dec. 2 article…
Read More
Carey & Danis filed a lawsuit in November alleging that a client developed a life-threatening disease after being given certain drugs in support of an MRI test. So our pharmaceutical…
Read More
As a dangerous medication lawyer, I was gratified to read that a woman from Peoria, Ill. was awarded $6.3 million in damages after a finding that her breast cancer was…
Read More
As a St. Louis defective drug attorney, I was disturbed to read about a new Food and Drug Administration warning of potential irreversible cartilage damage from certain anesthetics and medical…
Read More